Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy.

Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy.

Item
http://www.wikidata.org/entity/Q33585002
The hematopoietic stem cell transplantation in Indonesia: an unsolved dilemma.Non-myeloablative stem cell transplants.Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.An anti-human thymocyte globulin-based reduced-intensity conditioning regimen is associated with a higher quality of life and lower organ toxicity without affecting lymphocyte reconstitutionNonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.The war on cancer: a report from the front linesPharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.Non-myeloablative allogeneic hematopoietic stem cell transplantation.Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectorsAllogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure.Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens.Full chimerism in nonmyeloablative stem cell transplantation in a beta-thalassemia major patient (class 3 Lucarelli).Nonmyeloablative stem cell transplantation with a haploidentical donor in a class 3 lucarelli severe thalassemia patient.
P2860

Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy.

Item
http://www.wikidata.org/entity/Q33585002
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@ast
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@nl
type
label
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@ast
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@nl
prefLabel
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@ast
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
P2093
P304
P31
P356
10.1097/00001622-199903000-00003
P433
P478
P577
P698
P921